NUWE NASDAQ
Nuwellis, Inc.
1W: -10.6%
1M: -6.1%
3M: -78.9%
YTD: -61.7%
1Y: -78.4%
3Y: -100.0%
5Y: -100.0%
$0.69
-0.06 (-7.37%)
Weekly Expected Move ±21.4%
$0
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships9
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2022-12-29
Earliest Filing
2026-01-30
Latest Filing
partner: 7
target: 1
supplier: 1
Counterparties (Filed by NUWE)
9 relationshipsCompanies named in NUWE's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Rendiatech, Ltd. | — | target | Target company in asset acquisition transaction for Clarity RMS and Clarity Prime technology. | 2026-01-30 | View |
| Ladenburg Thalmann & Co. Inc. | — | partner | Entered into an At The Market Offering Agreement to act as sales agent or principal for the sale of common stock. | 2025-09-03 | View |
| Kluge Design, LLC | — | supplier | Manufacturing and service provider for the Aquadex Blood Circuit, dELC Catheter, and SmartFlow Console. | 2025-05-12 | View |
| Roth Capital Partners, LLC | — | partner | Placement agent for the registered public offering of common stock and warrants. | 2024-05-01 | View |
| Equiniti Trust Company, LLC | — | partner | Transfer agent and warrant agent for the common warrants sold in the offering. | 2024-05-01 | View |
| Lake Street Capital Markets, LLC | — | partner | Placement agent for the Series J Convertible Preferred Stock offering | 2023-10-17 | View |
| Maxim Group LLC | MMS | partner | Placement agent for the Series J Convertible Preferred Stock offering | 2023-10-17 | View |
| Equiniti Trust Company, LLC | — | partner | Warrant agent for the offering | 2023-10-17 | View |
| DaVita Inc. | DVA | partner | Entered into a Supply and Collaboration Agreement for a pilot program of the Aquadex ultrafiltration therapy system. | 2023-06-21 | View |
Mentioned As Counterparty
1 mentionsOther companies that named NUWE in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-26 | Regulation FD; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-08-03 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-07-24 | Shareholder Vote | View | |
| 2026-06-24 | Bylaws Amendment; Exhibits | View | |
| 2026-06-18 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-10 | Regulation FD; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-04-29 | Shareholder Vote | View | |
| 2026-04-24 | Other Events | View | |
| 2026-04-01 | Officer/Director Change; Exhibits | View | |
| 2026-03-27 | Officer/Director Change; Exhibits | View | |
| 2026-03-17 | Other Events | View | |
| 2026-03-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-26 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Other Events; Fi | View | |
| 2026-01-30 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2026-01-23 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-08 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-09-30 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR